Susan Hasty, Publisher
Table of Contents . . . April 21st, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Medical Letter on the CDC and FDA | Other Publications
Cholera - 20 cents-a-dose vaccine safe and immunogenic
Tooth Decay - Community water fluoridation now reaches nearly two-thirds of U.S. population
Infertility - ART associated with significant increased risk for multiple births
Product Recalls - FDA pulls jelly candies due to choking hazard
Smallpox - U.S. Army scientists achieve research breakthrough
Acute Care - High turnover rate may undermine HIV/hemophilia care
Arthritis - FDA approval for indomethacin extended-release capsules
Depression - Antidepressant SNEC-2 begins phase I clinical trial
Infectious Disease - U.S. Army to test company's antibiotics as potential anti-bioterrorism drugs
Influenza - CDC calls flu season a mild one, says plenty of vaccine still available
Measles - Measles no longer endemic disease in U.S.
Ovarian Cancer - Ciphergen confirms use of its ProteinChip system
Tuberculosis - Morbidity among foreign-born populations in United States rises
Whooping Cough - Cases in the U.S. are on the rise again
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.